Third-generation continuous flow left ventricular assist devices

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

Volumn 5, Issue 4, 2010, Pages 250-258

  Nguyen, Duc Q ^a   Thourani, Vinod H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Continuous flow; Heart failure; Magnetic levitation; Third generation LVAD

Indexed keywords

CLINICAL TRIAL; HEART ASSIST DEVICE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ASSIST DEVICE; HUMAN; HYDRODYNAMICS; MAGNETISM; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS INFECTION; REVIEW;

EID: 77956232847     PISSN: 15569845     EISSN: 15590879     Source Type: Journal    
DOI: 10.1097/IMI.0b013e3181ee77a1     Document Type: Review

References (51)

1. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122: 1186-1195.
2. El-Banayosy A, Arusoglu L, Kizner L, et al. Novacor left ventricular assist system versus HeartMate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg. 1000;119:581-587.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
4. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID trial. J Am Coll Cardiol. 2007;50:741-747.
5. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998:2383-2389.
6. Maybaum S, Kamalakannan G, Murthy S. Cardiac recovery during mechanical assist device support. Semin Thorac Cardiovasc Surg. 2008; 20:234-246.
7. Olsen DB. The history of continuous-flow blood pumps. Artif Organs. 2000;24:401-404.
8. Pagani FD. Continuous-flow rotary left ventricular assist devices with "3rd generation" design. Semin Thorac Cardiovasc Surg. 2008;20:255-263.
9. Antaki JF, Poirier V, Pagani FD. Engineering concepts in the design of mechanical circulatory support. In: Frazier OH, Kirklin JK, eds. Mechanical Circulatory Support. Philadelphia, PA: Elsevier Inc.; 2006:33-52.
10. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007; 357:885-896.
11. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
12. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 2003;237:631-637.
13. Siegenthaler MP, Frazier OH, Beyersdorf F, et al. Mechanical reliability of the Jarvik 2000 heart. Ann Thorac Surg. 2006;81:1752-1759.
14. Goldstein DJ. Worldwide experience with the MicroMed DeBakey ventricular assist device as a bridge to transplantation. Circulation. 2003;108(Suppl I):II272-II277.
15. Westaby S, Frazier OH, Banning A. Six years of continuous mechanical circulatory support. N Engl J Med. 2006;355:325-327.
16. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
17. Takatani S. Progress of rotary blood pumps. Artif Organs. 2006;30:317-321.
18. Jahanyar J, Noon GP, Koerner MM, et al. Recurrent device thrombi during mechanical circulatory support with an axial-flow pump is a treatable condition and does not preclude successful long-term support. J Heart Lung Transplant. 2007;26:200-203.
19. Delgado R III, Frazier OH, Myers TJ, et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005;24:231-233.
20. Ranjit J. Current axial-flow devices\the HeartMate II and Jarvik 2000 left ventricular assist devices. Semin Thorac Cardiovasc Surg. 2008;20: 264-272.
21. Saito S, Westaby S, Piggot D, et al. Reliable long-term non-pulsatile circulatory support without anticoagulation. Eur J Cardiothorac Surg. 2001;19:678-683.
22. Schmid C, Jurmann M, Birnbaum D, et al. Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. J Heart Lung Transplant. 2008;27:253-260.
23. El-Banayosy A, Koerfer R, Nojiri C. The DuraHeart left ventricular assist system requires less intensive anticoagulation. J Heart Lung Transplant. 2008;27(Suppl 1):S162.
24. Boyle AJ, Griffith BP, Ascheim DD, et al. The VentrAssist LVAD as a bridge to cardiac transplantation: results of the U.S. feasibility trial. J Heart Lung Transplant. 2008;27(Suppl 1):S246.
25. Esmore D, Kaye D, Spratt P, et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant. 2008;27:579-588.
26. Matsumura F, Okada Y, Fujita M, Namerikawa T. State of the art of magnetic bearings. JSME Int J. 1997;40:553-560.
27. Beams JW. Magnetic suspension for small rotors. Rev Sci Inst. 1950; 21:182-184.
28. Akamatsu T, Nakazeki T, Itoh H. Centrifugal blood pump with a magnetically suspended impeller. Artif Organs. 1992;16:305-308.
29. Akamatsu T, Tsukiya T, Nishimura K, et al. Recent studies of the centrifugal blood pump with a magnetically suspended impeller. Artif Organs. 1995;19:631-634.
30. Allaire PE, Kim HC, Maslen EH, et al. Prototype continuous flow ventricular assist device supported on magnetic bearings. Artif Organs. 1996;20:582-590.
31. Hoshi H, Shinshi T, Takatani S. Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs. 2006;30:324-338.
32. Earnshaw S. On the nature of molecular forces which regulated the constitution of the luminiferous ether. Trans Camb Phil Soc. 1842;7(Part 1):97-112.
33. Jahanmir S, Hunsberger AZ, Heshmat H, et al. Performance characterization of a rotary centrifugal left ventricular assist device with magnetic suspension. Artif Organs. 2008;32:366-375.
34. Nojiri C, Kijima T, Maekawa J, et al. Development status of Terumo implantable left ventricular assist system. Artif Organs. 2001;25:411-413.
35. Nojiri C, Fey O, Jaschke F, et al. Long-term circulatory support with the DuraHeart maglev centrifugal left ventricular assist system for advanced heart failure patients eligible to transplantation: European experiences. J Heart Lung Transplant. 2008;27(Suppl 1):S245.
36. Nishinaka T, Schima H, Roethy W, et al. The DuraHeart VAD, a magnetically levitated centrifugal pump: the University of Vienna bridge-to-transplant experience. Circ J. 2006;70:1421-1425.
37. Griffith K, Jenkins E, Pagani FD. First American experience with the Terumo DuraHeart left ventricular assist system. Perfusion. 2009;24: 91-92.
38. Tuzun E, Roberts K, Cohn WE, et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J. 2007; 34:406-411.
39. Wood C, Maiorana A, Larbalestier R, et al. First successful bridge to myocardial recovery with a HeartWare HVAD. J Heart Lung Transplant. 2008;27:695-697.
40. Wieselthaler GM, Strueber M, O'Driscoll GA, et al. Experience with the novel HeartWare HVAD with hydromagnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 2008;27(Suppl 1): S245.
41. Schmid C, Tjan TD, Etz C, et al. First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant. 2005;24:1188-1194.
42. Hetzer R, Weng Y, Potapov EV, et al. First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur J Cardiothorac Surg. 2004;25:964-970.
43. Gottel P, Hetzer R, Schmid C, et al. Clinical results of the first 99 patients with the axial flow pump Incor. J Heart Lung Transplant. 2005;24(Suppl 1):S57.
44. Pitsis AA, Visouli AN, Vassilikos V, et al. First human implantation of a new rotary blood pump: design of the clinical feasibility study. Hellenic J Cardiol. 2006;47:368-376.
45. Esmore D, Spratt P, Larbalestier R, et al. VentrAssist left ventricular assist device: clinical trial results and clinical development plan update. Eur J Cardiothorac Surg. 2007;32:735-744.
46. Esmore DS, Kaye D, Salamonsen R, et al. Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial. J Heart Lung Transplant. 2008;27:479-485.
47. Ruygrok PN, Esmore DS, Alison PM, et al. Pediatric experience with the VentrAssist LVAD. Ann Thorac Surg. 2008;86:622-626.
48. Esmore DS, Kaye D, Salamonsen R, et al. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure. J Heart Lung Transplant. 2005;24:1150-1154.
49. Loree HM, Bourque K, Gernes DB, et al. The HeartMate III: design and in vivo studies of a maglev centrifugal left ventricular assist device. Artif Organs. 2001;25:386-391.
50. Farrar DJ, Bourque K, Dague CP, et al. Design features, development status, and experimental results with the HeartMate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO J. 2007;53:310-315.
51. Ren Z, Jahanmir S, Heshmat H, et al. Design analysis and performance assessment of hybrid magnetic bearings for a rotary centrifugal blood pump. ASAIO J. 2009;55:340-347.